相关实验视频

Updated: Aug 10, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

在肺腺癌预后中识别和验证与代谢相关的基因,使用生物信息学分析

Yun Chen1, Ping Li2, Yang Wang1

  • 1Department of Thoracic Surgery, the First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

Frontiers in genetics
|October 31, 2025
PubMed
概括

这项研究确定了四个关键基因 (F2,GPX3,KMO,KYNU) 参与代谢,预测肺腺癌 (LUAD) 的结果. 这些发现可能会为LUAD患者的新治疗策略提供信息.

关键词:
药物敏感性 药物敏感性免疫疗法反应的免疫疗法反应肺部腺癌的癌症.预测模型的预测模型.的代谢 的代谢瘤微环境是一个微环境.

更多相关视频

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

751
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

714

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...